Stock Quote
Teva Pharmaceutical Industries Ltd (TEVA.O) (Nasdaq)
$52.72
20 Nov 2009
-0.60%
$53.04
$52.74
4,089,937
$53.08
$52.50
$54.95
$39.75
0.27
4,352,278
TEVA.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Hurvitz, Eli | Chairman of the Board | -- |
| Yanai, Shlomo | Chief Executive Officer, President | -- |
| Frost, Phillip | Vice Chairman of the Board | -- |
Profile
Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson’s... Full Description
Company Address
Teva Pharmaceutical Industries Ltd
5 Basel Street
PO Box 3190
Petach Tikva 49131
P: +9723.9267267
F: +9723.9267472
5 Basel Street
PO Box 3190
Petach Tikva 49131
P: +9723.9267267
F: +9723.9267472
Analyst Research
| TEVA.O | Industry | |
|---|---|---|
| P/E(TTM) | 57.70 | 3.57 |
| P/S(TTM) | 3.64 | 0.57 |
| ROI(TTM) | 4.18 | 1.86 |
| ROE(TTM) | 5.47 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 3.15 |
| Total Revenue | $13,525.50M |
| Net Income | $2,484.12M |
| EPS | $2.70 |
